发明名称 TRPV1媒介性疾患治療剤
摘要 An object of the present invention is to find a novel pharmacological action of a urea compound having a structure represented by the general formula [I]. The urea compound having a structure represented by the general formula [I] or a salt thereof has an excellent therapeutic effect on a TRPV1-mediated disease. In the formula, A represents a lower alkylene group or a lower alkenylene group; R 1 represents a hydrogen atom, an alkyl group which may have a substituent or an alkenyl group which may have a substituent; and R 2 and R 3 are the same or different and represent a hydrogen atom or a lower alkyl group which may be substituted by a monocyclic cycloalkyl group, a polycyclic cycloalkyl group, or an aryl group.
申请公布号 JP5853043(B2) 申请公布日期 2016.02.09
申请号 JP20140062892 申请日期 2014.03.26
申请人 あゆみ製薬株式会社 发明人 隠樹 健二;辻 文雄;瀬戸口 尋子;關 巌;村井 正明;笹野 稔
分类号 A61K31/4409;A61P1/00;A61P1/04 主分类号 A61K31/4409
代理机构 代理人
主权项
地址